Sinopharm
1099.HK
#2828
Rank
ยฃ4.46 B
Marketcap
ยฃ1.43
Share price
1.16%
Change (1 day)
-21.42%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: ยฃ62.12 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is ยฃ62.12 Billion. In 2025 the company made a revenue of ยฃ62.12 Billion an increase over the revenue in the year 2024 that were of ยฃ60.51 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025ยฃ62.12 B2.65%
2024ยฃ60.51 B-5.1%
2023ยฃ63.77 B5.42%
2022ยฃ60.49 B-2.1%
2021ยฃ61.78 B16.85%
2020ยฃ52.87 B14.95%
2019ยฃ46.00 B21.52%
2018ยฃ37.85 B5.93%
2017ยฃ35.73 B27.22%
2016ยฃ28.08 B5.37%
2015ยฃ26.65 B9.14%
2014ยฃ24.42 B17.22%
2013ยฃ20.83 B25.94%
2012ยฃ16.54 B34.61%
2011ยฃ12.29 B55.34%
2010ยฃ7.91 B35.79%
2009ยฃ5.82 B37.56%
2008ยฃ4.23 B31.43%
2007ยฃ3.22 B40.26%
2006ยฃ2.29 B